Prognostic Role of Transfusion Requirement and Validation of the IPSS Prognostic System in Myelodisplastic Syndromes.Flavia Salvi, Alessandro Levis, Margherita Bonferroni et al.|Blood|2006Cited by 0
Improvement of Remission Duration with Low-Dose Post-Remissional Gemtuzumab Ozogamicin (GO) in Elderly Patients with Acute Myeloid LeukemiaFilippo Marmont, Umberto Vitolo, Ernesta Audisio et al.|Blood|2008Cited by 0